• Hope and hype: Inside the push for wearable diabetes technology

    by on April 2nd, 2018

    Want to make a billion dollars? Here’s a hot tip: Invent wearable technology that detects diabetes, measures glucose levels, and determines how much insulin is needed – all without the need for a single drop of blood. If you accept this mission, there’s a catch: You’ll have a whole bunch of company. When it comes […]

  • Pot legalization tied to drop in opioid prescribing rates

    by on March 30th, 2018

    FROM JAMA INTERNAL MEDICINE Laws covering medical or recreational use of marijuana are associated with reduced rates of opioid prescribing among federal health care program enrollees, results of two recently published investigations show. In one study, researchers investigated whether medical cannabis access affected opioid prescribing in Medicare Part D, the federal program that subsidizes cost […]

  • Certifications, training to increase addiction medicine specialists

    by on March 30th, 2018

    Two new workforce developments aim to increase the number of addiction medicine specialists and provide new training opportunities in the subspecialty. The American Board of Medical Specialties (ABMS) recently certified its first formal wave of addiction medicine physicians, adding 1,200 specialists to the field. Addiction medicine was first recognized as a subspecialty by ABMS in […]

  • Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly

    by on March 30th, 2018

    REPORTING FROM THSNA 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – A simple intervention of initial warfarin dose capping in hospitalized patients aged 85 years and older led to significant reductions in supratherapeutic INRs without a significant change in length of stay, a single-center study showed. “We’re excited to see if these results are reproducible,” Jonathan […]

  • Always get culture in symptomatic children with neurogenic bladder

    by on March 30th, 2018

    FROM PEDIATRICS In the symptomatic child with neurogenic bladder at risk for urinary tract infection (UTI), urine culture should be performed regardless of the results of urinalysis, recommended Catherine S. Forster, MD , of Cincinnati Children’s Hospital Medical Center, and her associates. In a general pediatric population, studies have found that certain uropathogens – such […]

  • Protocol helped identify hospitalized children at risk for VTE

    by on March 30th, 2018

    REPORTING FROM THSNA 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Following simple institutional care guidelines helped clinicians identify pediatric patients at moderate-to-severe risk of venous thromboembolism (VTE), results from a single-center study showed. “Hospital-acquired VTE is on the rise in the pediatric population,” lead study author Emily Southard, MD, said at the biennial summit of […]

  • Single screening for Lynch syndrome beats sequential tests in CRC

    by on March 30th, 2018

    FROM JAMA ONCOLOGY Physicians could more accurately test patients with colon cancer for Lynch syndrome by using a single tumor sequencing test instead of the current protocol of up to six sequential tests, a new study suggests. The process may also be faster in some cases. “We found that up-front tumor testing is actually more […]

  • Think about breast cancer surveillance for transgender patients

    by on March 30th, 2018

    REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Both transgender men and transgender women had an increased risk of breast cancer compared with a male, but not a female, reference population, said Christel de Blok, MD, sharing results of a Dutch national study. The study included 3,078 transgender people (2,064 transgender women) who began […]

  • Higher preconception blood pressure linked to pregnancy loss

    by on March 30th, 2018

    FROM HYPERTENSION High preconception blood pressure is associated with a greater risk of pregnancy loss, according to analysis of data from a randomized clinical trial of aspirin and pregnancy outcomes. Researchers in the EAGeR (Effects of Aspirin on Gestational and Reproduction) trial analyzed data from 1,228 women attempting pregnancy with a history of pregnancy loss. […]

  • Prior bariatric surgery may lead to IBD

    by on March 30th, 2018

    FROM ALIMENTARY PHARMACOLOGY AND THERAPEUTICS Bariatric surgery increases the risk of new-onset inflammatory bowel disease (IBD), according to a case series and national database study. “A past history of bariatric surgery, but not recent surgery, was associated with both new-onset” Crohn’s disease and ulcerative colitis, wrote Ryan Ungaro, MD, assistant professor of medicine at the […]

  • Federal budget grants $1.8 billion to Alzheimer’s and dementia research

    by on March 30th, 2018

    Congress has appropriated an additional $414 million for research into Alzheimer’s disease and other dementias – the full increase requested by the National Institutes of Health for fiscal year 2018. The boost brings the total AD funding available this year to $1.8 billion. Bolstered by the mandate of the National Plan to Address Alzheimer’s Disease […]

  • Balloon pulmonary angioplasty for CTEPH improves heart failure symptoms

    by on March 30th, 2018

    REPORTING FROM CRT 2018 WASHINGTON (FRONTLINE MEDICAL NEWS) – Balloon pulmonary angioplasty provides meaningful improvements in functional capacity for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are not candidates for surgical pulmonary thromboendarterectomy, according to a single-center experience with 15 consecutive patients that was presented at CRT 2018 sponsored by the Cardiovascular Research Institute […]

  • Checkpoint inhibition less toxic than antiangiogenic therapy in NSCLC

    by on March 30th, 2018

    REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Checkpoint blockade is associated with reduced toxicity when compared with antiangiogenic therapies for the treatment of advanced non–small-cell lung cancer, a systematic review and meta-analysis suggests. In 16,810 patients from 37 trials included in the analysis, first-line treatment with nivolumab or pembrolizumab, compared with […]

Back to top